Companies
Mylab Discovery Solutions
- Country
- India
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Capacity | 200,000 RT-PCR and 50,000 RNA tests (as of 2020) | pib.gov.in |
| Certification | ISO 9001, ISO 13485, WHO-GMP compliant, CE-IVD marked | biobase.whitefordresearch.com · mylabglobal.com · careratings.com |
| Regulatory approval | CDSCO/India-FDA approved manufacturing facilities and products (including NAT, HIV, HBV, HCV, COVID-19) | mylabglobal.com · careratings.com · pib.gov.in |
| Production site | Lonavala, Maharashtra (registered and main facility); Global Innovation Center in Baner, Pune (corporate office/R&D) | biobase.whitefordresearch.com · mylabglobal.com · thecompanycheck.com |
| Headcount | 164 employees (as of May 1, 2025) | thecompanycheck.com |
| Revenue | Between ₹100 crore and ₹500 crore (FY 2024) | thecompanycheck.com |
Independent sources: biobase.whitefordresearch.com · careratings.com · mylabglobal.com · pib.gov.in · thecompanycheck.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Diagnostics & biosensors | diagnostics-medtech | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.